Moreover, SAM68 is frequently upregulated in PCa patients and promotes PCa cell proliferation and survival to chemotherapeutic agents [46], suggesting a role for this pathway in prostate cancer biology. This evidence concerns the gene KHDRBS1 and prostate cancer.